Outlook Therapeutics OTLK
NASDAQ OTLK
$0.44 -0.04 (-7.51%)
As of: Nov 12, 2026 · 12:51 PM EST

Outlook Therapeutics (OTLK) Amortization of Intangibles (2024 - 2026)

Updated

Analysis

Outlook Therapeutics (OTLK) Amortization of Intangibles (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.70 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.06 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 608.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00 13,791.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13,791.00
Mar 31, 2026 30,417.00
Dec 31, 2025 30,074.00
Sep 30, 2025 29,737.00
Jun 30, 2025 29,412.00
Mar 31, 2025 29,102.00
Dec 31, 2024 28,801.00
Sep 30, 2024 28,797.00
API Access

Outlook Therapeutics Amortization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=OTLK&period=max&api_key=YOUR_API_KEY